MedPath

Augmented Reality Treadmill Training in Patients With Parkinson's Disease

Not Applicable
Recruiting
Conditions
Fall
Parkinson Disease
Interventions
Device: C-Mill augmented reality treadmill training
Registration Number
NCT04108741
Lead Sponsor
Klinik Valens
Brief Summary

Gait disorder is a disabling symptom in Parkinson's disease (PD) affecting all patients during the course. Three methods of treadmill training (TT) will be compared to assess additional augmented reality (AR), or additional dual task (DT). AR TT, DT TT, and TT alone applied over 3 weeks at each day will be compared for their impact on falls, walking, freezing and attention for 3 months in a double blinded randomized controlled trial during regular neurorehabilitation.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Informed Consent as documented by signature
  • Parkinson´s disease without dementia and hallucination
  • at least one fall within the past 3 months or postural instability
  • Gait disorder
  • Hoehn and Yahr stages II-IV
  • able to perform the treadmill therapy during a study
Exclusion Criteria
  • Contraindications to treadmill therapy (e.g. hip fracture)
  • Dementia as defined by an Montreal cognitive assessment (MOCA) < 20

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
treadmill trainingC-Mill augmented reality treadmill training-
treadmill training with augmented reality dual taskingC-Mill augmented reality treadmill training-
treadmill training with random number generation dual taskingC-Mill augmented reality treadmill training-
Primary Outcome Measures
NameTimeMethod
Frequency of falls3 months before study to 3 months following the study

group difference of the difference in falls

Secondary Outcome Measures
NameTimeMethod
Secondary outcomes:before and after the training period of 3 weeks

Freezing of Gait (FOG) Questionnaire

Sensor based gait analysesbefore and after the training period of 3 weeks and after 3 months

for one week

Trial Locations

Locations (1)

Department of Neurology

🇨🇭

Valens, Saint Gallen, Switzerland

© Copyright 2025. All Rights Reserved by MedPath